Antibodies as therapeutics for multiple sclerosis

ISSN： 2195-2175

Source： PHARMAKON, Vol.2, Iss.6, 2014-11, pp. : 403-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics

Medicinal Chemistry, Vol. 14, Iss. 2, 2018-02 ,pp. : 104-105

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies in the Treatment of Multiple Sclerosis

Current Medicinal Chemistry, Vol. 16, Iss. 36, 2009-12 ,pp. : 4858-4868

Bentham Science Publishers

Access to resources Recommend Favorite

Treating multiple sclerosis with monoclonal antibodies: a 2013 update

By Deiß Annika Brecht Isabel Haarmann Axel Buttmann Mathias

Expert Review of Neurotherapeutics, Vol. 13, Iss. 3, 2013-03 ,pp. : 313-335

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibodies: A Target Therapy for Multiple Sclerosis

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 2, 2014-05 ,pp. : 134-143

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis

By Gensicke Henrik Leppert David Yaldizli Özgür Lindberg Raija L.P. Mehling Matthias Kappos Ludwig Kuhle Jens

CNS Drugs, Vol. 26, Iss. 1, 2012-01 ,pp. : 11-37

Adis International

Access to resources Recommend Favorite